Pharmaceutical News

RSS

Many back pain patients taking opioids get limited relief and worry about side effects, study finds

Millions of people take opioids for chronic back pain, but many of them get limited relief while experiencing side effects and worrying about the stigma associated with taking them, suggests research presented at the ANESTHESIOLOGY 2016 annual meeting.

24 Oct 2016

Novel lipid-based therapeutic shows promise for combating drug resistance in AML

Researchers at the Medical University of South Carolina Hollings Cancer Center have discovered a mechanism that confers resistance to drugs used to treat certain types of acute myeloid leukemia (AML).

24 Oct 2016

RIT faculty-researcher receives grant to help design coordinated vaccine procurement system

Rochester Institute of Technology received a three-year, $374,949 grant from the Bill & Melinda Gates Foundation for faculty-researcher Rubén Proaño to study and help design a coordinated decision-support system for the global procurement of vaccines.

21 Oct 2016

MIT researchers develop imaging technique that provides unprecedented view of serotonin dynamics

Serotonin is a neurotransmitter that's partly responsible for feelings of happiness and for mood regulation in humans.

21 Oct 2016

Antimicrobial copper touch surfaces may help fight global threat of antibiotic resistance

A key presentation at the Infection Control show within the Patient First conference on 22 November will look at a simple engineering solution to help fight the global threat of antibiotic resistance: antimicrobial copper touch surfaces.

21 Oct 2016

Two leading non-profit organizations sign strategic affiliation to hasten drug development

The Scripps Research Institute and the California Institute for Biomedical Research - two leading non-profit research organizations - today announced the signing of a strategic affiliation that combines the two organizations into a new biomedical research entity with the tools and know-how to rapidly translate its scientific discoveries into life-saving medicines for the public benefit.

20 Oct 2016

Scientists modify structure of cancer drug to enhance ability to pass through blood-brain barrier

In efforts to develop new treatments for brain cancer, scientists from Johns Hopkins Drug Discovery and the Kimmel Cancer Center's Bloomberg~Kimmel Institute for Cancer Immunotherapy report they have altered the structure of an experimental drug that seems to enhance its ability to slip through the mostly impermeable blood-brain barrier.

20 Oct 2016

New study raises serious safety concerns in clinical use of caspase inhibitors for liver injury

Many acute and chronic liver diseases, including alcoholic hepatitis, result from apoptotic (programmed) cell death mediated by the enzyme caspase.

20 Oct 2016

TUM scientists uncover novel mechanisms of action for skin disease medication

Imiquimod is a medication successfully used in the treatment of skin diseases. In addition to its known mechanism of action, it also triggers other processes in the body.

20 Oct 2016

Novel Alzheimer's treatment uses microscopic droplets of fat to carry drugs into the brain

Researchers have developed a novel treatment that could block the development of Alzheimer's disease using microscopic droplets of fat to carry drugs into the brain.

20 Oct 2016

Compound bearing hidden chirality can trigger autocatalytic preparation of chiral organic intermediates

The preparation of chiral compounds as intermediates in drug synthesis is one of the most important targets in synthetic organic chemistry.

20 Oct 2016

New bio-photonic device aims to take drug hypersensitivity detection into new era

Over 2.5 million people in Europe and more than 5.4 million Americans suffer from hypersensitivity to Beta Lactam Antibiotics (BLCs), the most commonly prescribed drugs that contain the penicillin family, with up to 10 percent of people reporting an allergy.

20 Oct 2016

FDA approves new therapy for initial treatment of soft tissue sarcoma

The U.S. Food and Drug Administration today granted accelerated approval to Lartruvo (olaratumab) with doxorubicin to treat adults with certain types of soft tissue sarcoma (STS), which are cancers that develop in muscles, fat, tendons or other soft tissues.

19 Oct 2016

Johns Hopkins wins $16 million contract to find ways to optimize antibiotic prescribing

Superbugs are causing a super problem in health care, but combating these drug-resistant bacteria presents quite a challenge.

19 Oct 2016

BetterYou’s oral spray effective in correcting vitamin D insufficiency in athletes, study shows

The findings of a study by Ulster University in conjunction with health pioneers BetterYou, have confirmed existing literature showing how athletes, despite spending an above average amount of time outdoors, are still at risk of vitamin D deficiency.

From BetterYou Ltd 19 Oct 2016

NPS MedicineWise encourages health professionals to participate in Antibiotic Awareness Week 2016

NPS MedicineWise is encouraging health professionals and community groups to get involved in the upcoming Antibiotic Awareness Week 2016.

19 Oct 2016

Domain Therapeutics and Medicxi partner to launch Mavalon Therapeutics

Domain Therapeutics, a biopharmaceutical company that specializes in the discovery and development of G protein-coupled receptor (GPCR) drugs, today announces the creation of Mavalon Therapeutics, a company focused on stopping the progression of Parkinson’s disease.

19 Oct 2016

Pharmaceutical News

Many back pain patients taking opioids get limited relief and worry about side effects, study finds

Novel lipid-based therapeutic shows promise for combating drug resistance in AML

RIT faculty-researcher receives grant to help design coordinated vaccine procurement system

MIT researchers develop imaging technique that provides unprecedented view of serotonin dynamics

Antimicrobial copper touch surfaces may help fight global threat of antibiotic resistance

Two leading non-profit organizations sign strategic affiliation to hasten drug development

Scientists modify structure of cancer drug to enhance ability to pass through blood-brain barrier

New study raises serious safety concerns in clinical use of caspase inhibitors for liver injury

TUM scientists uncover novel mechanisms of action for skin disease medication

Novel Alzheimer's treatment uses microscopic droplets of fat to carry drugs into the brain

Compound bearing hidden chirality can trigger autocatalytic preparation of chiral organic intermediates

New bio-photonic device aims to take drug hypersensitivity detection into new era

FDA approves new therapy for initial treatment of soft tissue sarcoma

Johns Hopkins wins $16 million contract to find ways to optimize antibiotic prescribing

BetterYou’s oral spray effective in correcting vitamin D insufficiency in athletes, study shows

NPS MedicineWise encourages health professionals to participate in Antibiotic Awareness Week 2016

Domain Therapeutics and Medicxi partner to launch Mavalon Therapeutics

Novel toothpaste produces significant reductions in dental plaque and inflammation

Folinic acid treatment could help improve language and communication skills of children with ASD

Study identifies factors that may contribute to use of PIMs at the end of life

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Latest News